文献速递糖尿病肥胖与代谢综合征

儿童1型糖尿病合并家族性高胆固醇血症:诊断与治疗的双重挑战

Familial Hypercholesterolemia in Pediatric Patients With Type 1 Diabetes: Double Challenge for Diagnosis and Treatment.
PubMed 文献 · Diabetes Care · 2025-01-01

本研究基于欧洲384个中心41,992名1型糖尿病儿童的回顾性队列数据(2014-2023),发现 probable FH 患病率为0.56%(1/215),possible FH 为1.2%。可能/很可能FH组BMI标准差评分和HbA1c更高、女性更多,但仅20%和29%接受降脂治疗。

要点

  • 儿童T1D中很可能FH患病率约1/215,可能FH约1.2%。
  • HbA1c>9%、女性、BMI>70百分位与LDL-C>2倍4.9 mmol/L风险升高相关。
  • 可能/很可能FH患儿仅20%/29%接受降脂治疗,治疗率不足。

核心结论

  • 儿童T1D中很可能FH患病率较高(1/215),多数可能受遗传FH影响并被HbA1c和BMI修饰。
  • 尽管FH合并T1D早发动脉粥样硬化风险极高,仅约三分之一接受降脂治疗。

研究设计与样本

  • 基于Diabetes Prospective Follow-Up registry的回顾性队列研究,分析2014-2023年384个欧洲中心41,992名儿童T1D数据。
  • 很可能FH定义为LDL-C>2倍且>4.9 mmol/L;可能FH定义为LDL-C>2倍且>4.1 mmol/L且≤4.9 mmol/L。

主要发现

  • 31,862名患者LDL-C持续<4.1 mmol/L,416名(1.2%)为可能FH,195名(0.56%)为很可能FH。
  • 可能FH和很可能FH组BMI标准差评分分别为0.73和0.55,高于LDL-C<4.1 mmol/L组的0.27(P<0.00001)。
  • 可能FH和很可能FH组HbA1c分别为8.2%(66 mmol/mol)和8.3%(67 mmol/mol),高于对照组的7.5%(58 mmol/mol)(P<0.00001)。
  • 可能FH和很可能FH组女性比例分别为57%和62%,高于对照组的44%(P<0.00001)。
  • LDL-C>2倍4.9 mmol/L的比值比:HbA1c>9%(>75 mmol/mol)为3.85(95%CI 2.6-5.7),HbA1c 7.5-9%(58-75 mmol/mol)为2.12(1.48-3.04),女性为2.10(1.56-2.81),BMI>70百分位为1.47(1.08-2.02)。

关键数值与推荐

  • 很可能FH:LDL-C>2倍且>4.9 mmol/L;可能FH:LDL-C>2倍且>4.1 mmol/L且≤4.9 mmol/L。
  • 可能FH组20%、很可能FH组29%接受降脂治疗。

临床怎么用

  • 对儿童T1D应关注LDL-C水平,按上述标准识别可能/很可能FH。
  • 合并FH的T1D患儿动脉粥样硬化风险极高,应积极评估并启动降脂治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Familial hypercholesterolemia (FH) and type 1 diabetes (T1D) are both common and without adequate treatment, lead to premature atherosclerosis and cardiovascular events. We identified children with T1D and probable FH and analyzed their lipid-lowering therapy (LLT). RESEARCH DESIGN AND METHODS: This retrospective cohort study was based on the Diabetes Prospective Follow-Up registry, analyzing data of 41,992 children (2014-2023) with pediatric T1D from 384 European centers. Classification of probable FH was >2× LDL cholesterol (LDL-C) >4.9 mmol/L and of possible FH, >2× LDL-C >4.1 mmol/L and ≤4.9 mmol/L. RESULTS: A total of 31,862 patients consistently had LDL-C <4.1 mmol/L, 416 (1.2%) had possible FH, and 195 (0.56%) had probable FH. Compared with the LDL-C <4.1 mmol/L cohort, the possible FH and probable FH groups had higher BMI standard deviation scores (0.73 and 0.55 vs. 0.27, P < 0.00001) and higher HbA1c (8.2% [66 mmol/mol]) and 8.3% [67 mmol/L] vs. 7.5% [58 mmol/mol], P < 0.00001) and were more often female (57% and 62% vs. 44%, P < 0.00001). Odds ratios for LDL-C 2× >4.9 mmol/L were 3.85 (95% CI 2.6-5.7) for HbA1c >9% (>75 mmol/mol), 2.12 (1.48-3.04) for HbA1c 7.5-9% (58-75 mmol/mol), 2.10 (1.56-2.81) for female sex, and 1.47 (1.08-2.02) for BMI >70th percentile. In the possible FH and probable FH groups, 20% and 29% were receiving LTT, respectively. CONCLUSIONS: The prevalence of probable FH was high (1 in 215 children) in pediatric T1D. We assume that the majority are affected by genetic FH, modified by HbA1c and BMI. Despite the very high risk for premature atherosclerosis in patients with FH and T1D, only one-third receive LLT.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Becker M, Weiskorn J, Wiegand S, et al. Familial Hypercholesterolemia in Pediatric Patients With Type 1 Diabetes: Double Challenge for Diagnosis and Treatment. Diabetes Care. 2025. PMID: 41129620. doi:10.2337/dc25-1195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。